$ANIX insider trading
Over the last 12 months, Anixa Biosciences insiders reported 14 buys totaling $280K and no sales across SEC Form 4 filings.
- Bought · 12m
- $280K 14 events
- Sold · 12m
- — 0 events
- Events · 12m
- 14 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 3,000 | $2.75 | $8K | +0.5% | — |
| Sep 10, 2026 | Titterton Lewis H jrD | ▲ Buy | 10,000 | $2.73 | $27K | +1% | — |
| Sep 10, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $2.76 | $14K | +0.8% | — |
| Jul 31, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.47 | $17K | +0.8% | — |
| Jul 27, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.44 | $17K | +0.8% | — |
| Jul 27, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 3,188 | $3.37 | $11K | +0.5% | — |
| Jul 24, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 3,000 | $3.73 | $11K | +0.5% | — |
| Jul 20, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.46 | $17K | +0.8% | — |
| Jul 20, 2026 | Titterton Lewis H jrD | ▲ Buy | 12,000 | $3.47 | $42K | +1.2% | — |
| Jul 15, 2026 | Titterton Lewis H jrD | ▲ Buy | 2,797 | $3.28 | $9K | +0.3% | — |
| Jul 10, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.04 | $15K | +0.8% | — |
| Jun 16, 2026 | Titterton Lewis H jrD | ▲ Buy | 2,836 | $2.64 | $7K | +0.3% | — |
| Jun 12, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 21,000 | $2.5 | $53K | +3.4% | — |
| Jan 28, 2026 | Baskies Arnold MD | ▲ Buy | 10,000 | $3.04 | $30K | +8% | — |
Every $ANIX filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Anixa Biosciences filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ANIX feed.